Orthofix Medical Inc.
OFIXNASDAQHealthcare● Active
$9.69
$-0.60(-5.83%)
Market Cap$391685808
P/E Ratio—
52W High$16.99
52W Low$9.13
Orthofix Medical Inc. (OFIX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OFIX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
-$0.52
Est. -$0.68 · +23.5%
Revenue
$0.20B
Est. $0.20B · +0.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS🔥 5-Quarter EPS Beat Streak
OFIX reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | -$0.03 | — | — | — | $0.21B | — |
| ▲ Q2 FY2026 | May 5, 2026 | -$0.68 | -$0.52 | +23.5% | $0.20B | $0.20B | +0.2% |
| ▲ Q1 FY2026 | Feb 24, 2026 | -$0.19 | -$0.06 | +70.8% | $0.22B | $0.22B | +0.6% |
| ▲ Q4 FY2025 | Nov 4, 2025 | $0.12 | $0.20 | +66.7% | $0.21B | $0.20B | +2.8% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $0.04 | $0.13 | +225.0% | $0.20B | $0.20B | +1.0% |
| ▲ Q2 FY2025 | May 6, 2025 | -$0.17 | -$0.08 | +52.9% | $0.19B | $0.20B | -5.2% |
| ▼ Q1 FY2025 | Feb 25, 2025 | $0.06 | $0.02 | -66.7% | $0.22B | $0.20B | +8.0% |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$0.14 | $0.07 | +150.0% | $0.20B | $0.21B | -7.6% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
-$0.03
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
-$0.52
EPS Est.
-$0.68
EPS Surpr.
+23.5%
Revenue
$0.20B
Q1 FY2026
Feb 24, 2026Beat
EPS Actual
-$0.06
EPS Est.
-$0.19
EPS Surpr.
+70.8%
Revenue
$0.22B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
$0.20
EPS Est.
$0.12
EPS Surpr.
+66.7%
Revenue
$0.21B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$0.13
EPS Est.
$0.04
EPS Surpr.
+225.0%
Revenue
$0.20B
Q2 FY2025
May 6, 2025Beat
EPS Actual
-$0.08
EPS Est.
-$0.17
EPS Surpr.
+52.9%
Revenue
$0.19B
Q1 FY2025
Feb 25, 2025Miss
EPS Actual
$0.02
EPS Est.
$0.06
EPS Surpr.
-66.7%
Revenue
$0.22B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.07
EPS Est.
-$0.14
EPS Surpr.
+150.0%
Revenue
$0.20B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2027 | $-0.01 | $-0.01 | $-0.00 | 1 |
| Q3 FY2027 | $-0.19 | $-0.18 | $-0.18 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.3B | $0.3B | $0.3B | 2 |
| Q3 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q2 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q1 FY2028 | $0.2B | $0.2B | $0.2B | 2 |
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 3 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +23.5% | $12.01 | $12.44 | +3.58% |
| ▲ Q1 FY2026 | Feb 24, 2026 | +70.8% | $13.59 | $12.75 | -6.18% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +66.7% | $16.06 | $14.87 | -7.41% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +225.0% | $10.85 | $12.31 | +13.46% |
| ▲ Q2 FY2025 | May 6, 2025 | +52.9% | $13.54 | $12.06 | -10.93% |
| ▼ Q1 FY2025 | Feb 25, 2025 | -66.7% | $18.15 | $17.51 | -3.53% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +150.0% | $18.40 | $18.22 | -0.98% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +138.5% | $14.59 | $17.44 | +19.53% |
Q2 FY2026+3.58%
Report Date
May 5, 2026
EPS Beat/Miss
+23.5%
Price Before
$12.01
Price After
$12.44
Q1 FY2026-6.18%
Report Date
Feb 24, 2026
EPS Beat/Miss
+70.8%
Price Before
$13.59
Price After
$12.75
Q4 FY2025-7.41%
Report Date
Nov 4, 2025
EPS Beat/Miss
+66.7%
Price Before
$16.06
Price After
$14.87
Q3 FY2025+13.46%
Report Date
Aug 5, 2025
EPS Beat/Miss
+225.0%
Price Before
$10.85
Price After
$12.31
Q2 FY2025-10.93%
Report Date
May 6, 2025
EPS Beat/Miss
+52.9%
Price Before
$13.54
Price After
$12.06
Q1 FY2025-3.53%
Report Date
Feb 25, 2025
EPS Beat/Miss
-66.7%
Price Before
$18.15
Price After
$17.51
Q4 FY2024-0.98%
Report Date
Nov 7, 2024
EPS Beat/Miss
+150.0%
Price Before
$18.40
Price After
$18.22
Q3 FY2024+19.53%
Report Date
Aug 6, 2024
EPS Beat/Miss
+138.5%
Price Before
$14.59
Price After
$17.44
Avg Beat Reaction+1.58%
Avg Miss Reaction-3.53%
Beat Rate7 / 8 quarters
Largest Move+19.53% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OFIX ends December
Orthofix Medical Inc. (OFIX) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $-0.52 — beating the analyst consensus of $-0.68 by +23.5%. OFIX has beaten EPS estimates for 5 consecutive quarters. The next OFIX earnings date is expected around September 1, 2026.
Each quarter, investors track OFIX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OFIX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OFIX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OFIX earnings · 5 questionsOrthofix Medical Inc.'s next earnings report is expected around September 1, 2026. OFIX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OFIX historically reports after market close (AMC).
OFIX earnings datewhen is OFIX earningsOFIX next earnings datewhen does OFIX report earningsOFIX earnings calendar
▸ Source: FMP · Orthofix Medical Inc. SEC filings · US GAAP · Orthofix Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026